Nestlé’s strategic shift: F&B giant relinquishes peanut allergy business

05 Sep 2023 — Nestlé has divested from Palforzia, its peanut allergy business, to Stallergenes Greer, a biopharmaceutical company specializing in diagnosing and treating allergies. The deal’s value was not disclosed.